Medical Device Network on MSN
Ibex and HNL Lab Medicine partner for prostate cancer diagnostics
The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.
Add Yahoo as a preferred source to see more of our stories on Google. PSA stands for prostate-specific antigen, a substance naturally produced in prostate tissue. A small amount of PSA regularly ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity ...
Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...
Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the ...
High school students at Western Reserve Academy are gaining real-world research experience in cancer immunology, developing a ...
Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers ...
Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...
Seattle’s Alpenglow moves 3D microscope tech from lab to clinic to help modernize cancer diagnostics
Imaging of a rat heart created using Alpenglow Biosciences technology. (Photo courtesy of Azalia M. Martinez Jaimes and Karen M. Gonzalez of the Red Horse Lab at Stanford University) Seattle-based ...
Metastasis, the spread of cancer from a primary tumor to other parts of the body, is difficult to study in the lab, in part ...
A genetics research laboratory has reached a milestone in its efforts to recruit 1,000 volunteers for a prostate cancer study. CariGenetics, the first genomics company in the world dedicated solely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results